Clinical Trial Update: Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth [Phase 2]

View source ↗

Summary

A Phase 2 trial examining strategies to reduce nevirapine resistance mutations in HIV-infected pregnant women receiving antiretroviral drugs before and after de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2012-11-06